EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The intention of this trial is to evaluate safety and efficacy of a combination treatment of
EndoTAG-1 with Gemcitabine versus Gemcitabine monotherapy.